GIPC and IP Watchdog will host a discussion “on the partnership between different actors in the innovation ecosystem that have enabled our response to the global pandemic.” The discussion will also “describe the functioning of the biotechnology research and development ecosystem from early stage research through product development and clinical trials, as well as the diverse stakeholders involved and the relationships among them.”